Agenda

PHYSICIANS-IN-TRAINING BOOTCAMP

DIDACTIC GENERAL SESSION

STATION 1
Point-of-Care Echocardiography

STATION 2
Radiography: VQ & CTPA

STATION 3
DVT: Diagnosis, Management, Point-of-Care Compression Ultrasound

STATION 4
ICU Cases

STATION 5
Percutaneous Treatment

---

BPA-CTEPH ALLIANCE CONFERENCE

Welcome

Accessing the CTEPH patient for Balloon Pulmonary Angioplasty
CTEPH Overview
Transition from acute to chronic CTE disease: Lesions that are amenable to BPA

Technical Considerations…Not as Easy as it Looks
Is there a “standard” approach?

Minimizing Risks and Managing complications

What are the Outcomes to measure after the Intervention…and When?

BPA vs PH Targeted Medical Therapy for Inoperable CTEPH… A False Narrative?

Special Patient Groups:
Proximal vessel CTEPH
CTEPD
Post PTE surgery

Future Directions: What more is there to learn?

Closing Remarks

---

ANNUAL BUSINESS MEETING

BREAKFAST & INDUSTRY SATELLITE SESSIONS

SESSION 1: Welcome and Keynote

SESSION 2: Epidemiology Session

• The Worldwide Weight of VTE: Incidence, Management, and Economic Costs
• Bridging Borders: Collaborative Strategies to Combat the Global VTE Crisis
• Evolving Paradigms in PE Riskmanagement: A Dual Focus on Recurrence and Bleeding
• Equity in Thrombosis: Tackling Disparities in Pulmonary Embolism Treatment
• Panel discussion

SESSION 3: Diagnosis & Risk Stratification

• Case presentation
  
• Navigating the Currents: Today’s Landscape in PE risk stratification
• Pro: Risk Stratification for PE: Current Algorithms Fulfill Clinical Needs
• Con: Revamping Risk Stratifcation: The Urgent Need for Improved PE Algorithm
• Panel Discussion (Rapid fire questions in risk stratifcation, Audience questions)

SESSION 4: The times they are a-changin’ …Novel Paradigms for Identifying and Treating High Risk PE

• What do the latest data tell us about High Risk PE and what is missing
• Identifying “true” High Risk PE … A Tale of Three Patients
• Debate & Case Presentiation – “Hi-Risk PERT Alert: It’s a Bad One!!"
• Time Is of the Essence… Push That Bolus!!!
• Let’s Cool Off with ECMO… Stabilize the Situation!
• C’mon Folks, Get with the Program…Catheter-directed Therapy Now Reigns Supreme
• Surgical Embolectomy…Still Forgotten?
• Discussion and Debate

LUNCH AND INDUSTRY SATELLITE SESSIONS

SESSION 5: Tools of the Trade for Thrombus Resolution: A Decade of PERT

• The Devil We Know: State of the State: Contemporary Trends in Device Selection Based on Utilization Data
• The Devil We Don't Know: Limitations in Current Knowledge Base about Devices and Outcomes
• Debate & Case Presentiation: How I Devour My Clot!: The Challenge of Device Selection
• Keep it Simple: Just Thin It!
• Dissovle to Resolve
• Slice, Dice, & Lyse
• Aspirate
• Discussion and Debate

WORKSHOP A: ICU

• Medical management of the failing RV after PE
• Don’t intubate the critically ill PE patient!!! But when you have to…
• Bedside initiation of mechanical RV support
• Managing complications of catheter-based therapy in the ICU
• Discussion

WORKSHOP B: VENOUS DISEASE

• IVC Filters
• Deep Vein Thrombosis: Medical vs Endovascular
• Post-Thrombotic Syndrome
• Endovascular Treatment of Chronic Occlusion
• Panel

WORKSHOP C: STARTING & GROWING YOUR PERT

• Brief Overview & PERT Partners
• Experiences from PERT in Rural/Community
• What's Next? PERT 2.0: The Future
• PERT After Hospital - Fast Program
• PERT After Hospital

WORKSHOP D: PE CENTERS OF EXCELLENCE™

• Overview of PE Centers of Excellence™
• Value Proposition of PERT / How to Sell this to Your Health System
• Discussion and Q & A

SESSION 6: Oral Abstracts

• Abstract 1
• Abstract 2
• Abstract 3
• Q & A

SESSION 7: PE Game Show

POSTER SESSION & COCKTAIL RECEPTION

BREAKFAST & INDUSTRY SATELLITE SESSIONS

SESSION 8: Welcome and Keynote

SESSION 9: Live PERT Case

SESSION 10: Clinical Trials : Devices & Data, All You Need to Know

• IDE over the Line: Completed Single arm trials (FLARE, EXTRACT, RESCUE, APEX)
• Single arm studies: More devices and evidence on the way (Symphony, Enguld, Aventus, Akura, Innova)
• Trials in the pipeline
• Post Market Trials: FLAME, STRIKE PE, RESCUE-PE and RAPID-PE
• RCTs 1: HI-PEITHO, PEITHO 3, PE-TRACT
• RCTs 2: STORM-PE, PEERLESS, PEERLESS 2
• Panel Discussion: Where the Data Is Now and Where It is Going

SESSION 11: Post-PE Care

• Pathophysiology of Dyspnea after PE
• Brief survey of available tests and is there any data– 10 min (CT, Vq, RHC, TTE)
• Cases
• Anticoagulation Considerations
• Q & A

LUNCH AND INDUSTRY SATELLITE SESSIONS

SESSION 12: CTED/CTEPH MONITORING

• RPVO
• CTE__: Complications of RPVO other than CTEPH
• PTE
• BPA
• Medical management
• Panel Discussion

WORKSHOP E: NOT QUITE CTEPH: WHAT TO DO

• Defining the Problem. Who are we talking about?
• CTEPD: Watch or Intervene
• BPA in CTEPD: What is the Experience
• What to follow after Intervention
• Q & A

WORKSHOP F: ARTIFICIAL INTELLIGENCE

• Acute Diagnosis and Triage
• Chatbots and Other Language Models
• Longitudinal Patient Care Coordination
• Future Directions / Research
• Panel

WORKSHOP G: MCS BEYOND THE BASICS

• Case Challenge
• Interrupting the death spiral of acute PE- How does MCS address pathophysiology
• Proactive or reactive…When to initiate MCS?
• The "Art" of Cannulation
• When to extirpate and when to decannulate
• Roundtable discussion & Q & A with additional case challenges

SESSION 13: Best Papers of the Year

10th Anniversary Gala

SESSION 14: Welcome

SESSION 15: Meet the Experts

• PERT from the exPERTs…Controversies and Case Challenges
• Session 15: Challenge the Experts: What is the Right Answer
• Challenge Our Panel
• How We Do It
• Key Controversies and Case Challenges

SESSION 16: Medical Management

• Anticoagulation
• Anticoagulation Duration
• Thrombophilia pro/con
• Thrombophilia pro/con
• In or Out-Patient Care
• Discussion/Panel/ Q & A

SESSION 17: Special Populations

• Understanding Pulmonary Embolism in Women
• Clotting Conundrum: Pulmonary Embolism and Sickle Cell Disease
• More than a SOB Story: Impact of Pulmonary Embolism in Children
• Beyond the Surface: Pulmonary Embolism in Obese Individuals
• Q & A, Discussion

SESSION 18: Greatest Saves & Toughest Complications

• Case 1
• Case 2
• Case 3
• Q & A